Top compounds associated with response to IFI30


Feature Type Standardized
Nominal ANOVA
mRNA PD-0325901 gCSI pan-cancer AAC -0.19 0.001
mRNA selumetinib:BRD-A02303741 (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.12 0.001
mRNA regorafenib CTRPv2 pan-cancer AAC -0.12 0.001
mRNA BMS-195614 CTRPv2 pan-cancer AAC 0.13 0.001
mRNA Crizotinib CTRPv2 pan-cancer AAC -0.11 0.001
mRNA Rapamycin CTRPv2 pan-cancer AAC 0.11 0.001
mRNA GDC-0941 gCSI pan-cancer AAC 0.21 0.002
mRNA Imatinib CTRPv2 pan-cancer AAC -0.12 0.002
mRNA GDC-0941 CTRPv2 pan-cancer AAC 0.12 0.002
mRNA sirolimus:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.11 0.002
Download CSV